Volume 18 - Issue 2 - February 2005
Editor's Perspective »
$11,550,000. That is the settlement fund that DPMs and other specialty care providers will be able to draw from after enduring years of billing disputes with Cigna Healthcare. In December, the insurer decided to settle a national class action lawsuit filed by specialty health care providers and associated state and national associations including the American Podiatric Medical Association (APMA).
How significant is the settlement? In terms of the immediate financial remuneration, one podiatrist calls it a “drop in the bucket” compared to the revenue
Two podiatrists meet for dinner and one raises the possibility of merging their practices. “Why do we have two offices, two billing systems and two complete staffs?,” one may ask. “We each need another provider but not full time, and we each pay a different accountant to do the same thing. Is there something here that would make more sense?”
“Mergers and acquisitions.” That was the hot phrase we read about in the ‘80s and ‘90s. People often equated this phrase with larger market share, fewer expenses and more profit. Sometimes it was an
Diabetes Watch »
The field of advanced wound care science continues to deliver new products and concepts for use in healing problem wounds of the lower extremity. The market now includes two living cell products and numerous biologically active products that are the result of bioengineering research and development. The real advantage of these new technologies is that we can now actively stimulate healing whereas most of the prior advances in wound care simply helped to optimize the wound environment.
This ability to interact with the wound base and stimulate the producti
- « Previous
- | Page 2 of 2 |
- Next »